Visit to Klang manufacturing facility held in conjunction with 14th SMIIC Technical Committee Week 2025 in Kuala Lumpur -- ...
Zenas Biopharma’s lead autoimmune drug has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study. | Zenas Biopharma’s lead autoimmune drug ...
Metis' MTS-004 was safe and eased symptoms of pseudobulbar affect in people with MS and other neurological disorders, trial data show.
Sarah Chappell and her twin daughters Megan and Abbey Douglas-Chappell, 23, all graduated from the Open University (OU), in Milton Keynes. The family all studied together at their home in Cambridge ...
The early-stage pipeline for amyotrophic lateral sclerosis drugs exploded last year. After ALS R&D notched 28 new trial ...
VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug ...
Chowhound on MSN
Why Chocolate Is So Expensive (And How Researchers Might Put A Stop To Rising Prices)
Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...
Learn more about whether Biogen Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback